Safety Letter Notifications

Trial Interactive's Safety Letter Notifications is a validated, purpose-built solution designed to streamline the distribution, tracking, and acknowledgment of safety letters across clinical trial sites. Built for sponsors, CROs, and investigative sites, the platform automates critical safety communication workflows to ensure site staff are promptly informed about potential risks and adverse events, while maintaining full compliance with global regulatory requirements.

By replacing manual tracking processes with automated notifications, centralized dashboards, and integrated audit trails, Safety Letter Notifications minimizes the risk of missed communications and reduces administrative burden. The solution is designed with ease of use in mind, requiring minimal training for investigators and site staff, and supports standardization across products, protocols, countries, and sites.

Comprehensive Safety Letter Management

• Provides a validated, dedicated electronic repository to store and track safety letters and investigative site acknowledgements for products under clinical study
• Enables sponsors to build investigative site profiles, add contacts, and assign acknowledgement responsibilities to the appropriate personnel
• Ensures all safety event documents are viewed and acknowledged through automated tracking and configurable reminders
• Supports authoring, collaboration, and approval of safety letters via an optional workflow and document management process
• Offers flexible distribution of safety letters via system notifications or email attachments, with built-in tracking for non-system users
• Delivers comprehensive reporting through centralized dashboards covering pending, overdue, and completed acknowledgements, as well as site-specific compliance reports
• Maintains a 21 CFR Part 11-compliant audit trail that tracks all user, document, and workflow actions

Key Benefits

• Automated Compliance Tracking: Maintains adherence to global regulatory standards with integrated workflows that trigger follow-ups for overdue responses and support formal investigator acknowledgements
• Boosted Efficiency: Replaces manual tracking with automated notifications and oversight tools, ensuring no regulatory notification deadlines are missed through configurable reminders and alerts
• Risk Mitigation: Provides clear oversight tools to reduce the risk of missed safety communications, with central management of acknowledgements and team notifications tracked in the site communication log
• Regulatory Compliance: Detailed audit trails meet EMA, FDA, and other global regulatory requirements, supported by HITRUST-certified security to prevent data leakage or privacy issues
• Simplified Processes: Automated notifications and streamlined workflows ensure the right people at each site are notified and acknowledge receipt, with standardization across all relevant dimensions
• Ease of Use: Intuitive interface designed for investigators with minimal training requirements, with streamlined reporting providing clear accountability for audit readiness and patient safety

Key Features

• Validated and Compliant: Fully 21 CFR Part 11-compliant system with a comprehensive audit trail for complete regulatory assurance
• Efficient Distribution: Upload and distribute safety letters easily, with automated notifications and reminders for acknowledgements
• Central Oversight: Track acknowledgement statuses and manage compliance across all sites in real time
• Integrated Ecosystem: Import site data seamlessly and share acknowledgements directly with eTMF or eISF systems
• Designed for Your Team: Suitable for sponsors, CROs, investigators, and safety leads, ensuring efficient processes and regulatory compliance
• Advanced Reporting: KPI reports, compliance dashboards, and customizable reporting provide site-level insights for audit readiness

Trial Interactive's Safety Letter Notifications integrates within a broader clinical trial management ecosystem, supporting seamless data sharing with eTMF and eISF systems. With HITRUST-certified security and compliance with EMA, FDA, and 21 CFR Part 11 requirements, the platform is built to meet the rigorous demands of global clinical trial operations.